Livio Fertility Center, Göteborg, Sweden.
Ups J Med Sci. 2020 May;125(2):99-103. doi: 10.1080/03009734.2020.1737600. Epub 2020 Apr 1.
The use of intracytoplasmic sperm injection (ICSI) has been a major breakthrough in the treatment of male infertility. Even patients with non-obstructive azoospermia (NOA) may benefit from the ICSI technique to father a child as long as spermatogenesis is present. There are several techniques to recover testicular sperm in patients with NOA. However, retrieval of spermatozoa is unfortunately still only successful in a subset of patients with NOA, and the most superior sperm retrieval method is still under debate. A more recent technique, microdissection testicular sperm extraction (MD-TESE) with an operative microscope collecting larger and more opaque seminiferous tubules, is a non-blind sperm retrieval technique with theoretical benefits. The MD-TESE procedure seems to be feasible, effective, and safe in NOA patients but also more technically demanding and time-consuming compared with conventional blind techniques. In the present report, we describe our clinical experience and results from our first 159 MD-TESE procedures. The probability to retrieve sperm with the MD-TESE technique is high in NOA cases where earlier sperm retrieval with blind methods such as needle aspiration, percutaneous needle biopsy, or conventional TESE has failed.
卵胞浆内单精子注射(ICSI)的应用是男性不育治疗的重大突破。即使是非梗阻性无精子症(NOA)患者,只要存在生精,也可能受益于 ICSI 技术来生育孩子。有几种技术可以从 NOA 患者中回收睾丸精子。然而,不幸的是,在一些 NOA 患者中仍然无法成功获取精子,并且最优秀的精子获取方法仍在争论中。一种较新的技术是在手术显微镜下收集更大、更不透明的曲细精管的显微睾丸精子提取(MD-TESE),这是一种非盲取精技术,具有理论上的优势。与传统的盲取技术相比,MD-TESE 程序在 NOA 患者中似乎是可行、有效且安全的,但技术要求更高,耗时更长。在本报告中,我们描述了我们的临床经验和前 159 例 MD-TESE 手术的结果。在早期采用盲法(如抽吸针、经皮穿刺活检或传统 TESE)取精失败的 NOA 病例中,MD-TESE 技术获取精子的可能性很高。